MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹20,801 Cr | ₹20,663 Cr | ₹5,315 Cr | ₹5,358 Cr | ₹4,702 Cr |
What is the latest Total Non-Current Assets ratio of MANKIND PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹20,801 Cr |
| Mar2025 | ₹20,663 Cr |
| Mar2024 | ₹5,315 Cr |
| Mar2023 | ₹5,358 Cr |
| Mar2022 | ₹4,702 Cr |
How is Total Non-Current Assets of MANKIND PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹20,801 Cr | 0.66 | |
| Mar2025 | ₹20,663 Cr | 288.80 | |
| Mar2024 | ₹5,315 Cr | -0.81 | |
| Mar2023 | ₹5,358 Cr | 13.96 | |
| Mar2022 | ₹4,702 Cr | - | |
Compare Total Non-Current Assets of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹105,069.3 Cr | 1.2% | 6.6% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.2% |
6.6% |
-5% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses